Private Equity Info

JUNE 9, 2025

Two sectors stand out for their role in advancing healthcare: Pharmaceutical and Medicine Manufacturing This sector has been a magnet for PE interest due to its resilience, regulatory clarity, and innovation pipeline. Connect with 127,000 key executives across 16,000 firms and 33,000 funds, plus more than 1.3 million private companies.

Private Equity

CNBC: Investing

JULY 30, 2025

The bank downgraded the Danish pharmaceutical giant to neutral from buy and decreased its price target to $60. Skip Navigation Markets Pre-Markets U.S. That updated target still implies more than 11% upside from Tuesday's close.

Bank

CNBC: Investing

JUNE 9, 2025

Cardinal Health Josh — All three major Pharmaceutical Wholesalers made the list - McKesson (MCK) , Cencora (COR) and Cardinal Health (CAH) , only Cardinal looks good technically right now: CAH held its 50-day on a weekly closing basis during the April bloodbath, I'd use that area as a stop and update it each week.

Healthcare

Global Banking & Finance

DECEMBER 4, 2024

By Nell Mackenzie LONDON (Reuters) – Some of the world’s largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the prospects for pharmaceutical stocks after big share swings in the sector, eight sources told Reuters.

Funds

TM Capital

JULY 17, 2024

Josh has extensive experience completing transactions across key healthcare services sectors including physician practice management, ambulatory surgery centers, and pharmaceutical services.

Capital

Global Banking & Finance

FEBRUARY 5, 2024

Spain’s Grifols hires new CEO weeks after damaging short-seller report MADRID (Reuters) -Spanish pharmaceutical company Grifols hired a new chief executive and two founding family members will leave executive jobs, it said on Monday, four weeks after short-seller fund Gotham City questioned its accounting, triggering a share slump.

Pharmaceutical

Global Banking & Finance

NOVEMBER 27, 2024

MADRID (Reuters) -Canadian fund Brookfield is planning to drop its plan to take over Spain’s Grifols, two sources close to the matter said on Wednesday, sending shares in the pharmaceutical firm down 10%.

Shares

OfficeHours

JANUARY 26, 2024

This slowdown in sales has negatively impacted firms’ ability to raise money from investors, which have become reluctant to commit to new funds before seeing returns from previous vehicles. They need to invest remaining capital and go back to the market to raise new funds, which means a need to drive exits and improve distributions.”

Private Equity

Global Newswire by Notified: M&A

JULY 30, 2023

The sterility testing market is anticipated to grow substantially owing to the increasing investments and funding. The sterility testing market is anticipated to grow substantially owing to the increasing investments and funding. over the forecast period (2023-2030). over the forecast period (2023-2030).

Pharmaceutical

Shearman & Sterling

JANUARY 12, 2023

Lebanon County Employees' Retirement Fund v. The Company is a wholesale distributor of pharmaceuticals that faced extensive investigations and litigation related to the opioid epidemic. Collis, C.A. 2021-1118-JTL (Del.

Pharmaceutical

Mergers and Inquisitions

MAY 10, 2023

You can expect to see everything from energy , mining , and agricultural deals to real estate , consumer retail , chemicals , semiconductors, and pharmaceuticals ; technology has also become increasingly popular. 1,000 | Singapore: ~170 Hedge Funds: U.S.: To be fair, hedge fund activity anywhere outside the U.S. 7,200 | U.K.:

Investment Banking

Growth Business

MAY 31, 2023

How is it different to venture capital funding? VCs tend to use the money raised from various corporate investors into a strategically managed fund. Around 30 companies on average pitch to the network per year with some receiving follow-on funding. They can also differ by region and investment size.

Investment

How2Exit

OCTOBER 2, 2023

rn About The Guest(s): Corey Veverka is the owner of TBS, a company that specializes in validation and compliance for pharmaceutical manufacturing facilities. rn TBS specializes in validation and compliance for pharmaceutical manufacturing facilities, primarily through project-based work. New episodes 2x per week.

Business

Shearman & Sterling

JANUARY 12, 2023

Lebanon County Employees' Retirement Fund v. The Company is a wholesale distributor of pharmaceuticals that faced extensive investigations and litigation related to the opioid epidemic. Collis, C.A. 2021-1118-JTL (Del.

Pharmaceutical

Growth Business

OCTOBER 2, 2023

US-based funds showed themselves to be vigorously interested in expanding European and UK businesses, while large corporates invested into growth companies as a means of outsourcing R&D and innovation – patterns which are expected to be sustained this year.

Finance

Peak Frameworks

AUGUST 15, 2023

For instance, in 2020, shareholders of the pharmaceutical company Gilead Sciences voted on a proposal to reduce drug prices, signifying their ability to influence the company's policies. Institutional Shareholders Institutional shareholders are entities such as mutual funds, pension funds, and insurance companies that invest in shares.

Shares

Cooley M&A

JANUARY 22, 2020

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 2019 was a banner year for billion-dollar life sciences M&A transactions.

M&A

InvestmentBank.com

AUGUST 14, 2019

The benefits of VR are not limited to language immersion, architecture, interior design, space expedition, biology, chemistry or pharmaceutical practices. Furthermore, funding seems promising on a global scale. Geographically, 58% of funds were sourced from the United States with $5.5 There was $18.1 billion of investments, 18.6%

Education

Growth Business

NOVEMBER 21, 2023

Top of Santa’s wish-list of startups VCTs want to invest in, as 2023 draws to a close are, in no particular order: drug testing which avoids have to test pharmaceuticals on animals, ways to get renewable energy into businesses, and ventures specifically targeting the baby boomer generation, which today means those aged over 60.

Investment

Peak Frameworks

SEPTEMBER 12, 2023

A prime example is the pharmaceutical industry. Covering High Initial Costs or R&D Investments The initial stages of product development often involve high costs, especially in sectors like biotechnology, pharmaceuticals, and technology. Setting a High Initial Price Why would a company opt for a high initial price?

Pharmaceutical

Mergers and Inquisitions

NOVEMBER 1, 2023

PE firms view these companies as especially appealing since low multiples mean they can use higher debt percentages to fund the acquisitions. To be more specific, I would divide the sector into these four categories: Mega-Funds and Large PE Firms – None of these firms specializes in healthcare, but they all have sector teams.

Private Equity

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.

M&A

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity.

M&A

M&A Leadership Council

SEPTEMBER 26, 2024

Example : In a merger between two pharmaceutical companies, the IMO Lead had to manage the integration of R&D operations across both organizations. The R&D heads from each company had conflicting views on which product lines should receive priority funding post-merger.

Mergers and Acquisitions

Cooley M&A

APRIL 7, 2017

The term “indication” is often used in the biotech/pharmaceutical industry as a term of art, and to describe both developmental as well as commercial milestone events in an acquisition agreement. In this decision, the court determined that the word “indication” had multiple meanings in the oncology industry that are context specific.

Mergers and Acquisitions

Cooley M&A

JANUARY 30, 2024

To that end, many top activists stay close to private equity firms (or even activist buyout funds) to assess targets ripe for an M&A campaign. Activists are more keen to engage if they can champion a natural “fix” for issues in their campaign (i.e., Assembling a response team of seasoned advisers. [1]

Private Equity

Devensoft

AUGUST 24, 2023

Through financial synergy, organizations can access new funding sources, negotiate better terms with suppliers or customers, and optimize their capital structure. This integration led to the development of innovative drugs and treatments, enhancing Johnson & Johnson’s position as a healthcare leader.

Business

Cooley M&A

JANUARY 22, 2021

The second half of the year witnessed a rebound spurred by several multibillion-dollar deals, including Gilead’s acquisition of Immunomedics for nearly $21 billion and AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals for $39 billion. While deal value was down for the year, deal volume was relatively stable (down only 2.0%

M&A

Cooley M&A

JANUARY 20, 2022

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A

Cooley M&A

FEBRUARY 15, 2017

We are seeing funds increasingly fundraising for tech plays and are acquiring the needed sector expertise to build their tech portfolios. The continued publicity and political focus on drug pricing has created uncertainty in valuing specialty pharmaceutical and biotech companies.

M&A

Focus Investment Banking

MAY 14, 2025

Most recently, pharmaceutical company Johnson & Johnson announced a $55 billion investment in US manufacturing, as well as Hyundai Motors who announced a commitment of $21 billion in domestic manufacturing from 2025 to 2028.

Manufacturing

InvestmentBank.com

MAY 18, 2021

Government funded programs include Medicare, Medicaid, Children’s Health Insurance Program, and the Veterans Health Administration. The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare.

Healthcare

Global Newswire by Notified: M&A

JUNE 10, 2025

OQM has announced that AdBioTech is the corporate vehicle through which it wishes to pursue the funding and advancement of its immunotherapy assets. EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. AdBioTech”), a public company listed on KOSDAQ in South Korea.

Acquisitions

JD Supra: Mergers

APRIL 24, 2025

State attorneys general are playing an increasingly prominent role in shaping the antitrust enforcement landscape in the United States.

Pharmaceutical

Global Newswire by Notified: M&A

NOVEMBER 6, 2024

billion.

Capital

Growth Business

APRIL 10, 2025

By Anna Jordan on Growth Business - Your gateway to entrepreneurial success University spinouts continue to make an impression on the business landscape, securing millions during funding rounds and getting investment from some high-profile venture capitalists. It can depend on who provides the funding, too. Why the high rate?

Equities

Razorpay

APRIL 24, 2025

You then release funds to the vendor according to the agreed payment terms. Industries like manufacturing, pharmaceuticals, healthcare, food production, electronics, and aerospace benefit most from this approach. They verify that quantities, prices, quality standards, and other specifications match across all paperwork.

Accountant